The future of diabetes and obesity treatment is rapidly evolving
Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH)
For example: Peptides for weight loss can reduce obesity-related risks like diabetes, high blood pressure, and joint pain, which otherwise require ongoing treatment
Ji L, Jiang H, Cheng Z, Qiu W, Liao L, Zhang Y, et al
Menu adaptation should expand your range, not eliminate what works for the rest of your guests
eligibility typically requires a BMI of 35 kg/m or above (or 30 kg/m or above in certain ethnic groups), though thresholds vary by ICB Bariatric surgery referral for eligible patients, typically those with a BMI of 40 kg/m or above, or 35 kg/m or above with significant obesity-related comorbidities, in line with NICE guideline CG189 Structured diabetes prevention programmes for those at risk of type 2 diabetes These pathways offer genuine, monitored, and legally sanctioned routes to improved metabolic health